The Adult ADHD Self-Report Scale (ASRS) is a screening tool, not a diagnostic instrument, so interpreting your score means understanding what it flags rather than what it confirms. Developed by the World Health Organization, the ASRS exists in several versions with different scoring methods, and the number you get tells you whether your symptom pattern warrants a professional evaluation for ADHD. But the gap between a screening score and an actual diagnosis is wider than most people expect, and several common conditions can inflate your results.
Which Version Are You Looking At
The ASRS comes in multiple forms, and the scoring rules differ between them. The most widely circulated is the ASRS v1.1, which contains 18 questions covering the full range of ADHD symptoms defined by the DSM-IV. The first six of those questions form a quick screener called Part A, while the remaining twelve make up Part B. Part A is the piece most often used in clinics and online tools, and it is scored differently from the full checklist.
A newer version called the ASRS-5 was developed in 2017 using machine-learning techniques applied to pooled clinical data, and it aligns with the updated DSM-5 criteria for ADHD. It uses only six questions with weighted integer scoring, producing a total that ranges from 0 to 24. The ASRS-5 and the ASRS v1.1 screener look superficially similar because both are short, but they use different items and different math. If you filled one out online, check which version it was before interpreting the result.
How the ASRS v1.1 Screener Is Scored
The six-item Part A screener does not simply add up your raw answers. Each question asks how often you experience a particular symptom over the past six months, on a five-point scale from “never” to “very often.” But the threshold for scoring a point varies by item. For items 1 through 3, answering “sometimes,” “often,” or “very often” earns a point. For items 4 through 6, only “often” or “very often” count. A total of four or more points out of six is the standard cutoff indicating that further evaluation is warranted.
The full 18-item checklist uses the same asymmetric logic. Seven of the eighteen items award a point at the “sometimes” threshold, while the remaining eleven require “often” or “very often.” This design reflects the fact that some symptoms are common enough in the general population that only more frequent endorsement signals a clinical problem.
A study establishing US norms noted that this binary scoring method is how the validated screener works, but some clinicians also look at the raw 0-to-4 ratings across all 18 items to get a picture of overall symptom burden, since a person who answers “often” on twelve items has a heavier load than someone who answers “sometimes” on those same twelve, even if both cross the cutoff.
ASRS-5 Scoring and Cutoffs
The ASRS-5 was built to replace the older screener with something tuned to DSM-5 diagnostic criteria. Instead of simple pass/fail point counting, each of the six items carries a weighted score, and the weights differ by item and response level. The total ranges from 0 to 24, with a recommended screening cutoff of 14 or higher in adult general-population samples.
A validation study in adolescents found that a lower threshold, above 12, performed better for screening purposes in that age group, which hints at the broader principle that no single cutoff is perfect for every population. The ASRS-5 correlates very strongly with the older v1.1 total score, with correlation coefficients above 0.93 across total scores and above 0.88 for both the inattention and hyperactivity/impulsivity subscales. In practical terms, the two versions tend to flag the same people, but the ASRS-5 was designed to be more statistically efficient.
What “Screening Positive” Actually Means
Crossing the cutoff on any version of the ASRS means you are in a group that has a higher-than-average probability of meeting full diagnostic criteria for ADHD. It does not mean you have ADHD. The distinction matters because the ASRS trades some precision for the ability to catch most true cases. In a study comparing the ASRS v1.1 screener against structured diagnostic interviews, the sensitivity was around 84 to 88 percent, meaning it correctly flagged most people who did have ADHD. But specificity hovered around 66 to 67 percent, meaning roughly a third of people without ADHD also screened positive.
The full 18-item scale has a discriminative ability measured by an area under the curve of about 0.90, which is considered good for a self-report instrument. But “good for a screening tool” and “good enough to diagnose” are not the same bar. The ASRS is designed to be sensitive rather than specific, to cast a wide net. If you screen negative, you can feel fairly confident that ADHD is unlikely. If you screen positive, you have a reason to pursue a clinical evaluation, not a reason to assume the answer.
Why Positive Predictive Value Depends on Context
One of the least intuitive aspects of the ASRS is that the same score can mean very different things depending on who is being screened. In a study of treatment-seeking alcoholics, the ASRS v1.1 had a positive predictive value of only about 18 percent, meaning that fewer than one in five people who screened positive actually had ADHD when assessed with a thorough diagnostic interview. Yet the negative predictive value was nearly 98 percent. A study in treatment-seeking substance use disorder patients found a similarly low positive predictive value of 26 percent alongside a negative predictive value of 97 percent.
These numbers reflect the mathematical reality that when ADHD is relatively uncommon in the group being screened, most positive results will be false alarms. In a specialized ADHD clinic where the base rate of the condition is much higher, the same screener’s positive predictive value climbs substantially. This is why clinicians sometimes adjust the cutoff value downward or upward depending on the setting. In populations with substance use disorders, for instance, researchers have suggested lowering the cutoff to avoid missing cases, even though that increases false positives.
Depression and Anxiety Can Inflate Your Score
Perhaps the most common reason people get a misleading ASRS result is that depression and anxiety mimic several ADHD symptoms. Difficulty concentrating, restlessness, trouble finishing tasks, and feeling mentally scattered all show up in mood and anxiety disorders. A study of adults with major depressive disorder found that they endorsed all 18 ASRS items more frequently than healthy controls, and that the number of items endorsed correlated with their anxiety levels. The researchers concluded that a negative screen in someone with depression is highly informative, strongly suggesting ADHD is not present, but a positive screen in a depressed person needs careful follow-up to determine whether the symptoms are driven by the depression itself or by coexisting ADHD.
The overlap with anxiety is especially tricky for certain items. Research examining the ASRS’s factor structure in adults with anxiety disorders found that some hyperactivity items, such as difficulty relaxing and feeling driven by a motor, loaded more strongly onto clinical anxiety factors than onto ADHD factors when both conditions were analyzed together. In plain language, those particular items measure anxiety at least as much as they measure ADHD. Clinicians making a differential diagnosis are advised to look for ADHD evidence beyond just the overlapping hyperactivity symptoms.
Sex Differences in Screening Results
ADHD presents differently across sexes on average. Women are more likely to show predominantly inattentive symptoms while men more often display hyperactive-impulsive features. A study in a psychiatric outpatient population found notable discrepancies between the six-item screener and the full 18-item checklist: about 34 percent of participants screened above the cutoff on the short form, but only about 17 percent exceeded the cutoff on the longer version. Since the short screener overweights certain hyperactive items, it can flag people whose broader symptom profile does not actually cross the clinical threshold on the full instrument. This mismatch is one reason clinicians often follow a positive short-screen with the complete checklist or a structured interview rather than stopping at the six questions.
Self-Report Versus Clinician Assessment
A reasonable question when filling out any self-report questionnaire is whether your own perception of your symptoms lines up with what a trained evaluator would observe. Research comparing ASRS self-report scores with investigator-administered symptom ratings found strong correlations across the board, with coefficients between 0.78 and 0.89 for total scores and subscales covering inattention, hyperactivity, emotional functioning, and emotional dyscontrol. Those correlations held even after accounting for demographic factors and other psychiatric conditions.
That said, self-report has inherent limitations. A study examining self-report questionnaire scores in the context of performance validity found no relationship between executive function test performance and self-reported ADHD symptoms. The only factor that significantly predicted how people responded on the self-report measure was how they performed on symptom validity tests, instruments designed to detect whether someone is reporting honestly. This finding does not mean everyone exaggerates, but it underscores that ASRS scores reflect how you perceive and report your experience, which is not always the same as how your brain actually performs on objective tasks. For diagnosis, clinicians typically combine self-report with corroborating information, sometimes including reports from family members or partners.
Special Considerations for Substance Use Populations
ADHD and substance use disorders overlap more often than you might expect, and screening in this population is complicated in both directions. ADHD symptoms can be amplified by active substance use, withdrawal, and the general cognitive disruption that comes with addiction. At the same time, people in early recovery may underreport symptoms because they attribute their concentration problems to their substance use rather than to a separate condition.
Research on alcohol-dependent patients specifically noted that underreporting of ADHD symptoms on self-report scales like the ASRS is a genuine problem in this group, and that standard cutoff values may miss a substantial number of true cases. The recommendation for clinical settings was to lower cutoffs and accept the tradeoff of more false positives, because missing a treatable ADHD diagnosis in someone trying to recover from addiction carries real consequences. A separate validation in patients with various substance use disorders confirmed that the ASRS remains a useful tool in this population, though with the caveat that its positive predictive value drops considerably.
Using the ASRS to Track Treatment Response
Beyond screening, the ASRS can serve as a simple way to measure whether treatment is working. In a year-long open-label study of adults treated with stimulants or atomoxetine, ASRS scores were used as a primary outcome measure. Patients who stayed on medication showed a median 39 percent reduction in ASRS scores over the year, compared to only 13 percent in those who stopped. The ASRS tracked in parallel with improvements on a global functioning scale, suggesting it captures meaningful change rather than just noise.
If your clinician asks you to fill out the ASRS periodically during treatment, this is the reason. A declining score over several months is one indicator that medication or behavioral strategies are reducing your symptom burden. A score that stays flat or climbs back up prompts a conversation about whether the current approach needs adjustment. The scale works best for this purpose when you fill it out under similar conditions each time, since your answers can fluctuate based on stress, sleep, and how your week has been going.
Cross-Cultural Reliability
The ASRS has been translated and validated in dozens of languages. A large cross-cultural study spanning 42 countries found that the screener demonstrated good reliability and validity across different languages, countries, and genders, though the researchers noted partial rather than full measurement invariance. That means the tool works reasonably well worldwide, but subtle differences in how symptoms are expressed or interpreted across cultures mean that a score of, say, 15 on the ASRS-5 does not carry identical clinical meaning in every country.
A Czech validation study echoed a theme that runs through all the cross-cultural work: the ASRS has solid psychometric properties when compared to the English original, but it should not be used as a standalone diagnostic tool. The researchers recommended combining it with clinical judgment in every case. This is not a weakness unique to the Czech version. It applies universally. The ASRS was built as a first step, a way to efficiently identify who should be evaluated further. No translation changes that fundamental purpose.
When the Score Does Not Match How You Feel
Some people score below the cutoff despite genuinely struggling with attention and organization. Others score well above it and turn out not to have ADHD once a full evaluation is completed. Both scenarios are common, and neither should be cause for alarm.
If you score below the threshold but still suspect something is off, consider that the ASRS captures only a slice of what ADHD looks like. It asks about symptom frequency over six months but does not assess impairment, developmental history, or how symptoms have changed over your lifetime. Some adults have developed strong compensatory strategies that mask the frequency of their symptoms even as the underlying difficulties remain. Others have a presentation that the ASRS items simply do not capture well, particularly if their primary struggles involve emotional regulation or time perception rather than the classic inattention and fidgetiness.
If you score above the threshold, the path forward is the same regardless of how far above it you land. The ASRS does not come with severity bands that translate neatly into mild, moderate, or severe ADHD. A score of 5 out of 6 on the Part A screener does not necessarily indicate more severe ADHD than a score of 4. It indicates that more of your answers crossed the frequency threshold. The severity of your condition is something a clinician determines by looking at the full picture of your functioning, not by reading a single number off a screening form.
Response Bias and Honest Self-Assessment
The ASRS relies entirely on your subjective report, and that introduces a layer of uncertainty that no scoring algorithm can eliminate. Research has found that the primary predictor of self-report ADHD questionnaire scores was performance on symptom validity tests rather than actual performance on executive function and attention tasks. In other words, how honestly and carefully someone approaches the questionnaire matters more to the score than how well their brain actually handles attention-demanding tasks in a controlled setting.
This does not mean the ASRS is measuring nothing real. It means that self-awareness, mood state, motivation, and the context in which you fill out the form all contribute to the result. Someone completing the screener during a particularly stressful week, after a terrible night of sleep, or while actively wanting a diagnosis may score higher than they would under neutral conditions. Clinicians account for this by treating the ASRS as one data point among many, never as the final word.